- $34.71m
- $6.35m
- $10.02m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 10 | 10.8 | 10.6 | 10.2 | 10 |
Cost of Revenue | |||||
Gross Profit | 9.5 | 10.3 | 10.1 | 9.9 | 9.81 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 37.9 | 35.7 | 51.8 | 63.2 | 58.4 |
Operating Profit | -27.9 | -24.9 | -41.2 | -53 | -48.3 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -32.1 | -29.9 | -45.4 | -56.7 | -47.4 |
Net Income After Taxes | -32.1 | -29.9 | -45.4 | -56.7 | -47.4 |
Net Income Before Extraordinary Items | |||||
Net Income | -32.1 | -29.9 | -45.4 | -56.7 | -47.4 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -32.1 | -29.9 | -45.4 | -56.7 | -47.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -17.3 | -12.3 | -10.1 | -12.1 | -8.96 |